Browsed by
Category: Transhumanism

Fourth Enlightenment Salon – Political Segment: Discussion on Artificial Intelligence in Politics, Voting Systems, and Democracy

Fourth Enlightenment Salon – Political Segment: Discussion on Artificial Intelligence in Politics, Voting Systems, and Democracy

Gennady Stolyarov II
Bill Andrews
Bobby Ridge
John Murrieta


This is the third and final video segment from Mr. Stolyarov’s Fourth Enlightenment Salon.

Watch the first segment here.

Watch the second segment here.

On July 8, 2018, during his Fourth Enlightenment Salon, Gennady Stolyarov II, Chairman of the U.S. Transhumanist Party, invited John Murrieta, Bobby Ridge, and Dr. Bill Andrews for an extensive discussion about transhumanist advocacy, science, health, politics, and related subjects.

Topics discussed during this installment include the following:

• What is the desired role of artificial intelligence in politics?
• Are democracy and transhumanism compatible?
• What are the ways in which voting and political decision-making can be improved relative to today’s disastrous two-party system?
• What are the policy implications of the development of artificial intelligence and its impact on the economy?
• What are the areas of life that need to be separated and protected from politics altogether?

Join the U.S. Transhumanist Party for free, no matter where you reside by filling out an application form that takes less than a minute. Members will also receive a link to a free compilation of Tips for Advancing a Brighter Future, providing insights from the U.S. Transhumanist Party’s Advisors and Officers on some of what you can do as an individual do to improve the world and bring it closer to the kind of future we wish to see.

 

Fourth Enlightenment Salon – Health Segment: Discussions on GMOs, Calorie Restriction, Genetics, Artificial Sweeteners, CBD

Fourth Enlightenment Salon – Health Segment: Discussions on GMOs, Calorie Restriction, Genetics, Artificial Sweeteners, CBD

Gennady Stolyarov II
Bill Andrews
Bobby Ridge
John Murrieta


This is the second video segment from Mr. Stolyarov’s Fourth Enlightenment Salon. Watch the first segment here.

On July 8, 2018, during his Fourth Enlightenment Salon, Gennady Stolyarov II, Chairman of the U.S. Transhumanist Party, invited John Murrieta, Bobby Ridge, and Dr. Bill Andrews for an extensive discussion about transhumanist advocacy, science, health, politics, and related subjects.

Topics discussed during this installment include the following:

• Why genetically modified organisms (GMOs) are mostly good for you, and most negative perceptions of GMOs should really just be directed at the corporate practices of one company but not genetic modification as a whole.

• What technologies are already aiding the disabled and dramatically extending their capabilities in daily life.

• The role of genetics in longevity and the future of somatic genome editing.

• What the scientific evidence suggests regarding the impact of caloric restriction in humans and other primates.

• CBD and cannabinoids: separating the evidence from the marketing.

• Sierra Sciences’ history of testing over a million compounds for effects on telomerase induction.

• Why artificial sweeteners also should not be maligned, and there is no scientific evidence of their harms.

Join the U.S. Transhumanist Party for free, no matter where you reside by filling out an application form that takes less than a minute. Members will also receive a link to a free compilation of Tips for Advancing a Brighter Future, providing insights from the U.S. Transhumanist Party’s Advisors and Officers on some of what you can do as an individual do to improve the world and bring it closer to the kind of future we wish to see.

Fourth Enlightenment Salon – Gennady Stolyarov II, Bill Andrews, Bobby Ridge, and John Murrieta Discuss Transhumanist Outreach and Curing Disabilities

Fourth Enlightenment Salon – Gennady Stolyarov II, Bill Andrews, Bobby Ridge, and John Murrieta Discuss Transhumanist Outreach and Curing Disabilities

Gennady Stolyarov II
Bill Andrews
Bobby Ridge
John Murrieta


On July 8, 2018, during his Fourth Enlightenment Salon, Gennady Stolyarov II, Chairman of the U.S. Transhumanist Party, invited John Murrieta, Bobby Ridge, and Dr. Bill Andrews for an extensive discussion about transhumanist advocacy, science, health, politics, and related subjects. In this first of several installments from the Fourth Enlightenment Salon, the subjects of conversation include the following:

• The U.S. Transhumanist Party’s recent milestone of 1,000 members and what this portends for outreach toward the general public regarding the meaning of transhumanism and the many ways in which emerging technologies help make life better.

• The new channel – Science-Based Species – launched by Bobby and John to spread basic knowledge about transhumanism, key thinkers in the movement, and advances on the horizon.

• How today’s technologies to assist the disabled are already transhumanist in their effects, and how technologies already in development can liberate humans from disability altogether. John Murrieta’s story is one of transhumanism literally saving a life – and one of the most inspiring examples of how transhumanism translates into human well-being now and in the future.

Join the U.S. Transhumanist Party for free, no matter where you reside by filling out an application form that takes less than a minute. Members will also receive a link to a free compilation of Tips for Advancing a Brighter Future, providing insights from the U.S. Transhumanist Party’s Advisors and Officers on some of what you can do as an individual do to improve the world and bring it closer to the kind of future we wish to see.

“Squeak” – Art by Laura Katrin Weston, a.k.a. Katrin Brunier

“Squeak” – Art by Laura Katrin Weston, a.k.a. Katrin Brunier

Laura Katrin Weston



Commentary by Gennady Stolyarov II: “Squeak” is a print by Dr. Laura Katrin Weston, a.k.a. Katrin Brunier, the original exemplar of which I received in November 2017 due to my donation to the successful MouseAge crowdfunding campaign by Lifespan.io.

It is fitting for a project on mouse longevity to involve at least one image of mice – creatures whom life has unfortunately dealt a bad hand, due to their short lifespans (only 3 years for even long-lived mice in the absence of medical intervention), difficulty in getting along with humans, and unnecessary attrition due to disposal practices after lab experiments. “Squeak” invites the viewer to appreciate mice a bit more; if we can extend their lives significantly, we stand a decent chance of achieving dramatic extension of our own lifespans.  Perhaps we can also give some of the mice a break by using photographic markers of aging in experiments, as the MouseAge project seeks to do.

Here, the mice are depicted scurrying along a narrow circular path. The golden circle, with rays emanating outward represents perhaps the great hope that these creatures unknowingly provide to us. One may wonder, as I have done over many months of reflecting on this work, whether these are mutant, two-tailed mice, or whether they each just have their ordinary curly tails, and the track along which they move might simply be painted in the same colors and textures as their tails. (Well, in actuality it is indeed painted that way!) Mutant or not, these mice are rather extraordinary in having become emblems of a species that has added much to our understanding. Unlike most of their brethren to date, these mice have earned their extreme longevity through Laura Katrin Weston’s brush.

You can find more work by Dr. Laura Katrin Weston at the Katrin Brunier Gallery, an Ethical Investment-Grade Art Gallery for the Neo-Renaissance Era (see its Instagram page). Proceeds from art sales at the Katrin Brunier Gallery will go to support causes such as medical research and conservation.

What It Will Be Like to Be an 85-Year-Old in the 2070s – Article by Scott Emptage

What It Will Be Like to Be an 85-Year-Old in the 2070s – Article by Scott Emptage

Scott Emptage


I will be 85 sometime in the early 2070s. It seems like a mirage, an impossible thing, but the future eventually arrives regardless of whatever you or I might think about it. We all have a vision of what it is to be 85 today, informed by our interactions with elder family members, if nothing else. People at that age are greatly impacted by aging. They falter, their minds are often slowed. They are physically weak, in need of aid. Perhaps that is why we find it hard to put ourselves into that position; it isn’t a pleasant topic to think about. Four decades out into the future may as well be a science-fiction novel, a faraway land, a tale told to children, for all the influence it has on our present considerations. There is no weight to it.

When I am 85, there will have been next to no senescent cells in my body for going on thirty years. I bear only a small fraction of the inflammatory burden of older people of past generations. I paid for the products of companies descended from Oisin Biotechnologies and Unity Biotechnology, every few years wiping away the accumulation of senescent cells, each new approach more effective than the last. Eventually, I took one of the permanent gene therapy options, made possible by biochemical discrimination between short-term beneficial senescence and long-term harmful senescence, and then there was little need for ongoing treatments. Artificial DNA machinery floats in every cell, a backup for the normal mechanisms of apoptosis, triggered by lingering senescence.

When I am 85, the senolytic DNA machinery will be far from the only addition to my cells. I underwent a half dozen gene therapies over the years. I picked the most useful of the many more that were available, starting once the price fell into the affordable-but-painful range, after the initial frenzy of high-cost treatments subsided into business as usual. My cholesterol transport system is enhanced to attack atherosclerotic lesions, my muscle maintenance and neurogenesis operate at levels far above what was once a normal range for my age, and my mitochondria are both enhanced in operation and well-protected against damage by additional copies of mitochondrial genes backed up elsewhere in the cell. Some of these additions were rendered moot by later advances in medicine, but they get the job done.

When I am 85, my thymus will be as active as that of a 10-year-old child. Gene and cell therapies were applied over the past few decades, and as a result my immune system is well-gardened, in good shape. A combination of replacement hematopoietic stem cells, applied once a decade, the enhanced thymus, and periodic targeted destruction of problem immune cells keeps at bay most of the age-related decline in immune function, most of the growth in inflammation. The downside is that age-related autoimmunity has now become a whole lot more complex when it does occur, but even that can be dealt with by destroying and recreating the immune system. By the 2030s this was a day-long procedure with little accompanying risk, and the price fell thereafter.

When I am 85, atherosclerosis will be curable, preventable, and reversible, and that will have been the case for a few decades. There are five or six different viable approaches in the marketplace, all of which basically work. I used several of their predecessors back in the day, as well. Most people in the wealthier parts of the world have arteries nearly free from the buildup of fat and calcification. Cardiovascular disease with age now has a very different character, focused more failure of tissue maintenance and muscle strength and the remaining small portions of hypertension that are still problematic for some individuals. But that too can be effectively postponed through a variety of regenerative therapies.

When I am 85, there will be an insignificant level of cross-linking in most of my tissues, as was the case since my early 60s. My skin has the old-young look of someone who went a fair way down the path before being rescued. Not that I care much about that – I’m much more interested in the state of my blood vessels, the degree to which they are stiff and dysfunctional. That is why removal of cross-links is valuable. That is the reason to keep on taking the yearly treatments of cross-link breakers, or undergo one of the permanent gene therapies to have your cells produce protective enzymes as needed.

When I am 85, I will have a three-decade patchwork history of treatments to partially clear this form of amyloid or that component of lipofuscin. I will not suffer Alzheimer’s disease. I will not suffer any of the common forms of amyloidosis. They are controlled. There is such a breadth of molecular waste, however: while the important ones are addressed, plenty more remain. This is one of the continuing serious impacts to the health of older individuals, and a highly active area of research and development.

When I am 85, I will be the experienced veteran of several potentially serious incidences of cancer, all of which were identified early and eradicated by a targeted therapy that produced minimal side-effects. The therapies evolve rapidly over the years: a bewildering range of hyper-efficient immunotherapies, as well as treatments that sabotage telomere lengthening or other commonalities shared by all cancer cells. They were outpatient procedures, simple and quick, with a few follow-up visits, so routine that they obscured the point that I would be dead several times over without them. The individual rejuvenation technologies I availed myself of over the years were narrowly focused, not perfect, and not available as early as I would have liked. Cancer is an inevitable side-effect of decades of a mix of greater tissue maintenance and unrepaired damage.

Do we know today what the state of health of a well-kept 85-year-old will be in the 2050s? No. It is next to impossible to say how the differences noted above will perform in the real world. They are all on the near horizon, however. The major causes of age-related death today will be largely controlled and cured in the 2050s, at least for those in wealthier regions. If you are in your 40s today, and fortunate enough to live in one of those wealthier region, then it is a given that you will not die from Alzheimer’s disease. You will not suffer from other common age-related amyloidosis conditions. Atherosclerosis will be reliably controlled before it might kill you. Inflammatory conditions of aging will be a shadow of what they once were, because of senolytic therapies presently under development. Your immune system will be restored and bolstered. The stem cells in at least your bone marrow and muscles will be periodically augmented. The cross-links that cause stiffening of tissues will be removed. Scores of other issues in aging process, both large and small, will have useful solutions available in the broader medical marketplace. We will all live longer and in better health as a result, but no-one will be able to say for just how long until this all is tried.

Scott Emptage is an anti-aging activist in the United Kingdom. 

Third Enlightenment Salon – Gennady Stolyarov II, Bill Andrews, Bobby Ridge, and Mihoko Sekido Discuss Science-Based Advocacy of Transhumanism and Healthy Living

Third Enlightenment Salon – Gennady Stolyarov II, Bill Andrews, Bobby Ridge, and Mihoko Sekido Discuss Science-Based Advocacy of Transhumanism and Healthy Living

Gennady Stolyarov II
Bill Andrews
Bobby Ridge
Mihoko Sekido


The Third Enlightenment Salon, hosted by Gennady Stolyarov II on May 27, 2018, featured excellent conversations on the rise in public awareness of transhumanism and life extension and what can be done to further increase support for life-extending medical research. Dr. Bill Andrews, Bobby Ridge (a.k.a. Robert Ridge), and Mihoko Sekido shared insights on medical science, promotion of health, and methods of communicating the forthcoming convergence of advances in a wide array of technological fields. Importantly, we addressed how anyone can get involved in the transhumanist movement and improve public acceptance of the emerging technological future.

The following were some interesting areas of discussion:

– The new Telomere Coin, which will help fund Dr. Andrews’s research efforts – http://defytime.group/
– Bobby Ridge’s forthcoming new video channel – Science-Based Species
– Aspects of online videos that help increase their reach
– Factors that contribute to longer lifespans among Okinawans
– Motivators for leading a healthier lifestyle and its relation to the recognition of the possibility of indefinite life extension in our lifetimes
– Some potential health effects of metformin and the importance of the ongoing TAME clinical trials
– What anyone can do to promote life extension and other emerging technological fields – including joining the U.S. Transhumanist Party for free on this page.

This video also contains some excerpts from the remaining conversations at the Third Enlightenment Salon, including discussions of science-based medicine, promotion of transhumanism, autonomous vehicles, and responses to the prospect of longevity escape velocity.

Along with the recorded segment, there was much discussion about future directions of transhumanist initiatives, reasonably healthy food in a refined atmosphere, and previews of excellent video compilations that will become publicly available later this year. Mr. Stolyarov looks forward to hosting more Enlightenment Salons to bring together individuals in various fields of expertise and enable them to synthesize their insights into ways of comprehensively improving the human condition.

U.S. Transhumanist Party Chairman Gennady Stolyarov II Answers Common Interview Questions

U.S. Transhumanist Party Chairman Gennady Stolyarov II Answers Common Interview Questions

Gennady Stolyarov II


Gennady Stolyarov II, Chairman of the U.S. Transhumanist Party and Chief Executive of the Nevada Transhumanist Party, answers questions posed by Francesco Sacco, which are representative of common points of inquiry regarding transhumanism and the Transhumanist Party:

1. What is Transhumanism and what inspired you to follow it?
2. What are the long-term goals of the Transhumanist party?
3. What are your thoughts on death and eternal life through technological enhancements?
4. Do you feel there are any disadvantages to having access to the cure for death? What advantages are there?

Become a member of the U.S. Transhumanist Party for free, no matter where you reside. Fill out our Membership Application Form here.

See Mr. Stolyarov’s presentation, “The U.S. Transhumanist Party: Pursuing a Peaceful Political Revolution for Longevity“.

Review of Frank Pasquale’s “A Rule of Persons, Not Machines: The Limits of Legal Automation” – Article by Adam Alonzi

Review of Frank Pasquale’s “A Rule of Persons, Not Machines: The Limits of Legal Automation” – Article by Adam Alonzi

Adam Alonzi


From the beginning Frank Pasquale, author of The Black Box Society: The Secret Algorithms That Control Money and Information, contends in his new paper “A Rule of Persons, Not Machines: The Limits of Legal Automation” that software, given its brittleness, is not designed to deal with the complexities of taking a case through court and establishing a verdict. As he understands it, an AI cannot deviate far from the rules laid down by its creator. This assumption, which is not even quite right at the present time, only slightly tinges an otherwise erudite, sincere, and balanced coverage of the topic. He does not show much faith in the use of past cases to create datasets for the next generation of paralegals, automated legal services, and, in the more distant future, lawyers and jurists.

Lawrence Zelanik has noted that when taxes were filed entirely on paper, provisions were limited to avoid unreasonably imposing irksome nuances on the average person. Tax-return software has eliminated this “complexity constraint.” He goes on to state that without this the laws, and the software that interprets it, are akin to a “black box” for those who must abide by them. William Gale has said taxes could be easily computed for “non-itemizers.” In other words, the government could use information it already has to present a “bill” to this class of taxpayers, saving time and money for all parties involved. However, simplification does not always align with everyone’s interests. TurboTax’s business, which is built entirely on helping ordinary people navigate the labyrinth is the American federal income tax, noticed a threat to its business model. This prompted it to put together a grassroots campaign to fight such measures. More than just another example of a business protecting its interests, it is an ominous foreshadowing of an escalation scenario that will transpire in many areas if and when legal AI becomes sufficiently advanced.

Pasquale writes: “Technologists cannot assume that computational solutions to one problem will not affect the scope and nature of that problem. Instead, as technology enters fields, problems change, as various parties seek to either entrench or disrupt aspects of the present situation for their own advantage.”

What he is referring to here, in everything but name, is an arms race. The vastly superior computational powers of robot lawyers may make the already perverse incentive to make ever more Byzantine rules ever more attractive to bureaucracies and lawyers. The concern is that the clauses and dependencies hidden within contracts will quickly explode, making them far too detailed even for professionals to make sense of in a reasonable amount of time. Given that this sort of software may become a necessary accoutrement in most or all legal matters means that the demand for it, or for professionals with access to it, will expand greatly at the expense of those who are unwilling or unable to adopt it. This, though Pasquale only hints at it, may lead to greater imbalances in socioeconomic power. On the other hand, he does not consider the possibility of bottom-up open-source (or state-led) efforts to create synthetic public defenders. While this may seem idealistic, it is fairly clear that the open-source model can compete with and, in some areas, outperform proprietary competitors.

It is not unlikely that within subdomains of law that an array of arms races can and will arise between synthetic intelligences. If a lawyer knows its client is guilty, should it squeal? This will change the way jurisprudence works in many countries, but it would seem unwise to program any robot to knowingly lie about whether a crime, particularly a serious one, has been committed – including by omission. If it is fighting against a punishment it deems overly harsh for a given crime, for trespassing to get a closer look at a rabid raccoon or unintentional jaywalking, should it maintain its client’s innocence as a means to an end? A moral consequentialist, seeing no harm was done (or in some instances, could possibly have been done), may persist in pleading innocent. A synthetic lawyer may be more pragmatic than deontological, but it is not entirely correct, and certainly shortsighted, to (mis)characterize AI as only capable of blindly following a set of instructions, like a Fortran program made to compute the nth member of the Fibonacci series.

Human courts are rife with biases: judges give more lenient sentences after taking a lunch break (65% more likely to grant parole – nothing to spit at), attractive defendants are viewed favorably by unwashed juries and trained jurists alike, and the prejudices of all kinds exist against various “out” groups, which can tip the scales in favor of a guilty verdict or to harsher sentences. Why then would someone have an aversion to the introduction of AI into a system that is clearly ruled, in part, by the quirks of human psychology?

DoNotPay is an an app that helps drivers fight parking tickets. It allows drivers with legitimate medical emergencies to gain exemptions. So, as Pasquale says, not only will traffic management be automated, but so will appeals. However, as he cautions, a flesh-and-blood lawyer takes responsibility for bad advice. The DoNotPay not only fails to take responsibility, but “holds its client responsible for when its proprietor is harmed by the interaction.” There is little reason to think machines would do a worse job of adhering to privacy guidelines than human beings unless, as mentioned in the example of a machine ratting on its client, there is some overriding principle that would compel them to divulge the information to protect several people from harm if their diagnosis in some way makes them as a danger in their personal or professional life. Is the client responsible for the mistakes of the robot it has hired? Should the blame not fall upon the firm who has provided the service?

Making a blockchain that could handle the demands of processing purchases and sales, one that takes into account all the relevant variables to make expert judgements on a matter, is no small task. As the infamous disagreement over the meaning of the word “chicken” in Frigaliment v. B.N.S International Sales Group illustrates, the definitions of what anything is can be a bit puzzling. The need to maintain a decent reputation to maintain sales is a strong incentive against knowingly cheating customers, but although cheating tends to be the exception for this reason, it is still necessary to protect against it. As one official on the  Commodity Futures Trading Commission put it, “where a smart contract’s conditions depend upon real-world data (e.g., the price of a commodity future at a given time), agreed-upon outside systems, called oracles, can be developed to monitor and verify prices, performance, or other real-world events.”

Pasquale cites the SEC’s decision to force providers of asset-backed securities to file “downloadable source code in Python.” AmeriCredit responded by saying it  “should not be forced to predict and therefore program every possible slight iteration of all waterfall payments” because its business is “automobile loans, not software development.” AmeriTrade does not seem to be familiar with machine learning. There is a case for making all financial transactions and agreements explicit on an immutable platform like blockchain. There is also a case for making all such code open source, ready to be scrutinized by those with the talents to do so or, in the near future, by those with access to software that can quickly turn it into plain English, Spanish, Mandarin, Bantu, Etruscan, etc.

During the fallout of the 2008 crisis, some homeowners noticed the entities on their foreclosure paperwork did not match the paperwork they received when their mortgages were sold to a trust. According to Dayen (2010) many banks did not fill out the paperwork at all. This seems to be a rather forceful argument in favor of the incorporation of synthetic agents into law practices. Like many futurists Pasquale foresees an increase in “complementary automation.” The cooperation of chess engines with humans can still trounce the best AI out there. This is a commonly cited example of how two (very different) heads are better than one.  Yet going to a lawyer is not like visiting a tailor. People, including fairly delusional ones, know if their clothes fit. Yet they do not know whether they’ve received expert counsel or not – although, the outcome of the case might give them a hint.

Pasquale concludes his paper by asserting that “the rule of law entails a system of social relationships and legitimate governance, not simply the transfer and evaluation of information about behavior.” This is closely related to the doubts expressed at the beginning of the piece about the usefulness of data sets in training legal AI. He then states that those in the legal profession must handle “intractable conflicts of values that repeatedly require thoughtful discretion and negotiation.” This appears to be the legal equivalent of epistemological mysterianism. It stands on still shakier ground than its analogue because it is clear that laws are, or should be, rooted in some set of criteria agreed upon by the members of a given jurisdiction. Shouldn’t the rulings of law makers and the values that inform them be at least partially quantifiable? There are efforts, like EthicsNet, which are trying to prepare datasets and criteria to feed machines in the future (because they will certainly have to be fed by someone!).  There is no doubt that the human touch in law will not be supplanted soon, but the question is whether our intuition should be exalted as guarantee of fairness or a hindrance to moving beyond a legal system bogged down by the baggage of human foibles.

Adam Alonzi is a writer, biotechnologist, documentary maker, futurist, inventor, programmer, and author of the novels A Plank in Reason and Praying for Death: A Zombie Apocalypse. He is an analyst for the Millennium Project, the Head Media Director for BioViva Sciences, and Editor-in-Chief of Radical Science News. Listen to his podcasts here. Read his blog here.

Gennady Stolyarov II Interviewed by Nikola Danaylov of Singularity.FM

Gennady Stolyarov II Interviewed by Nikola Danaylov of Singularity.FM

Gennady Stolyarov II
Nikola Danaylov


On March 31, 2018, Gennady Stolyarov II, Chairman of the U.S. Transhumanist Party, was interviewed by Nikola Danaylov, a.k.a. Socrates, of Singularity.FM. A synopsis, audio download, and embedded video of the interview can be found on Singularity.FM here. You can also watch the YouTube video recording of the interview here.

Apparently this interview, nearly three hours in length, broke the record for the length of Nikola Danaylov’s in-depth, wide-ranging conversations on philosophy, politics, and the future.  The interview covered both some of Mr. Stolyarov’s personal work and ideas, such as the illustrated children’s book Death is Wrong, as well as the efforts and aspirations of the U.S. Transhumanist Party. The conversation also delved into such subjects as the definition of transhumanism, intelligence and morality, the technological Singularity or Singularities, health and fitness, and even cats. Everyone will find something of interest in this wide-ranging discussion.

Visit the U.S. Transhumanist Party website at http://transhumanist-party.org. To help advance the goals of the U.S. Transhumanist Party, as described in Mr. Stolyarov’s comments during the interview, become a member for free, no matter where you reside. Click here to fill out a membership application.

Beginners’ Explanation of Transhumanism – Presentation by Bobby Ridge and Gennady Stolyarov II

Beginners’ Explanation of Transhumanism – Presentation by Bobby Ridge and Gennady Stolyarov II

Bobby Ridge
Gennady Stolyarov II


Bobby Ridge, Secretary-Treasurer of the U.S. Transhumanist Party, and Gennady Stolyarov II, Chairman of the U.S. Transhumanist Party, provide a broad “big-picture” overview of transhumanism and major ongoing and future developments in emerging technologies that present the potential to revolutionize the human condition and resolve the age-old perils and limitations that have plagued humankind.

This is a beginners’ overview of transhumanism – which means that it is for everyone, including those who are new to transhumanism and the life-extension movement, as well as those who have been involved in it for many years – since, when it comes to dramatically expanding human longevity and potential, we are all beginners at the beginning of what could be our species’ next great era.

Become a member of the U.S. Transhumanist Party for free, no matter where you reside.

See Mr. Stolyarov’s presentation, “The U.S. Transhumanist Party: Pursuing a Peaceful Political Revolution for Longevity“.

In the background of some of the video segments is a painting now owned by Mr. Stolyarov, from “The Singularity is Here” series by artist Leah Montalto.